Preeclampsia affects 4% to 5% of pregnancies worldwide and is defined by new-onset hypertension accompanied by multiorgan involvement, including uteroplacental dysfunction.
1 The exact cause and pathogenesis of preeclampsia remain unknown, but there is consensus that generalized endothelial dysfunction plays an important role.
1 Thrombophilia can be either acquired or inherited and has been reported to be associated with an increased risk of preeclampsia.
1-3 Likewise, thrombophilia is associated with an increased risk of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism—an association also observed among women during pregnancy and puerperium.
4,5 Besides thrombophilia, known VTE risk factors include obesity, heart failure, cancer, inflammatory and autoimmune diseases, and venous insufficiency.
2,3 As VTE remains one of the leading causes of maternal mortality,
4 identifying women at increased risk is of great importance in terms of prevention.